Evidence map›Paper›PMID 22206816›Full record

ArticleEuropean journal of pharmacology2012

Riluzole and gabapentinoids activate glutamate transporters to facilitate glutamate-induced glutamate release from cultured astrocytes.

Masaru Yoshizumi, James C Eisenach, Ken-ichiro Hayashida

Open access · greenAbstract read
In one paragraph

Article in European journal of pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery.The international journal of neuropsychopharmacology · 2016
    Review
  11. Review
  12. Article
  13. Riluzole partially rescues age-associated, but not LPS-induced, loss of glutamate transporters and spatial memory.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2013
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Masaru YoshizumiDepartment of Anesthesiology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
James C Eisenach
Ken-ichiro Hayashida
Wake Forest University · US

Funding

Spinal Noradrenergic Sprouting after Nerve InjuryR01NS057594 · NINDS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI EISENACH, JAMES · 2008 to 2012
$1.7M
Mechanisms and Consequences of Locus Coeruleus ActivationR01DA027690 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HAYASHIDA, KENICHIRO · 2010 to 2014
$1.4M
NIDA NIH HHS DA27690NIDA NIH HHS R01 DA027690NINDS NIH HHS NS59574NINDS NIH HHS R01 NS057594
6 · The paper itself

Abstract

We have recently demonstrated that the glutamate transporter activator riluzole paradoxically enhanced glutamate-induced glutamate release from cultured astrocytes. We further showed that both riluzole and the α(2)δ subunit ligand gabapentin activated descending inhibition in rats by increasing glutamate receptor signaling in the locus coeruleus and hypothesized that these drugs share common mechanisms to enhance glutamate release from astrocytes. In the present study, we examined the effects of riluzole and gabapentin on glutamate uptake and release and glutamate-induced Ca(2+) responses in primary cultures of astrocytes. Riluzole and gabapentin facilitated glutamate-induced glutamate release from astrocytes and significantly increased glutamate uptake, the latter being completely blocked by the non-selective glutamate transporter blocker DL-threo-β-benzyloxyaspartic acid (DL-TBOA). Riluzole and gabapentin also enhanced the glutamate-induced increase in intracellular Ca(2+) concentrations. Some α(2)δ subunit ligands, pregabalin and L-isoleucine, enhanced the glutamate-induced Ca(2+) response, whereas another, 3-exo-aminobicyclo[2.2.1]heptane-2-exo-carboxylic acid (ABHCA), did not. The enhancement of glutamate-induced intracellular Ca(2+) response by riluzole and gabapentin was blocked by the DL-TBOA and an inhibitor of Na(+)/Ca(2+) exchange, 2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiurea (KB-R7943). Gabapentin's enhancement of Ca(2+) increase was specific to glutamate stimulation, as it was not mimicked with stimulation by ATP. These results suggest that riluzole and gabapentin enhance Na(+)-glutamate co-transport through glutamate transporters, induce subsequent Ca(2+) influx via the reverse mode of Na(+)/Ca(2+) exchange, and thereby facilitate Ca(2+)-dependent glutamate release by glutamate in astrocytes. The present study also demonstrates a novel target of gabapentinoid action in astrocytes other than α(2)δ subunits in neurons.

Indexed as

AminesAmino Acid Transport System X-AGAnimalsAstrocytesBiological TransportCalciumCells, CulturedCyclohexanecarboxylic AcidsGabapentingamma-Aminobutyric AcidGlutamic AcidIntracellular SpaceLigandsProtein SubunitsRatsRiluzoleAminesAmino Acid Transport System X-AGCalciumCyclohexanecarboxylic AcidsGabapentingamma-Aminobutyric AcidGlutamic AcidLigandsProtein SubunitsRiluzoleSodium

Identifiers

PMID22206816
PMCPMC3268950
OpenAlexW2036875480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.